Research
Endeavor reports phase 2b success for potential IPF drug
Endeavor said its mid-stage IPF trial succeeded, with results suggesting the drug could reduce lung fibrosis and increase total lung capacity.
Reported by 2 outlets · Thursday, October 8, 2026
The original reports on this story are listed below.
Infectious disease
Plague has not been confirmed in the worker’s death, and the WHO is seeking more information from Russia about the cause and testing.
Reported by 7 outlets
Drugs and FDA
The FDA expects to finish its safety study by mid-December and report its findings no later than March 2027.
Reported by 5 outlets
Vaccines
HHS opened an NIH clinic to study post-vaccination health problems and said it will add patient electronic health records to vaccine-related reports.
Reported by 4 outlets